Celon Pharma S.A.
An integrated pharmaceutical company researching and manufacturing modern drugs.
CLN | WAR
Overview
Corporate Details
- ISIN(s):
- PLCLNPH00015 (+3 more)
- LEI:
- 259400Q0ERJT0NC5DT24
- Country:
- Poland
- Address:
- KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY
- Website:
- https://celonpharma.com/en/
- Sector:
- Manufacturing
Description
Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-01-29 14:26 |
Terminy przekazywania raportów okresowych w 2020 roku - Content (PL)
|
Polish | 708 bytes | ||
| 2020-01-13 08:16 |
Aktualizacja informacji o wynikach toczących się sporów sądowych dotyczących sp…
|
Polish | 1.6 KB | ||
| 2019-12-21 09:47 |
Złożenie wniosku o spotkanie konsultacyjne w FDA - Content (PL)
|
Polish | 765 bytes | ||
| 2019-12-16 16:03 |
Złożenie wniosku o zgodę na rozpoczęcie badania klinicznego I fazy agonisty rec…
|
Polish | 1.3 KB | ||
| 2019-11-19 18:44 |
Uzyskanie europejskiego patentu w zakresie inhibitorów PI3K - Content (PL)
|
Polish | 1.4 KB | ||
| 2019-11-08 19:19 |
Zawarcie umów z NCBR o dofinansowanie dwóch projektów Spółki - Content (PL)
|
Polish | 1.7 KB | ||
| 2019-11-08 17:20 |
Celon SA-Q3
|
Polish | 2.1 MB | ||
| 2019-10-18 15:12 |
Zakończenie procedury rejestracyjnej dla leku Salmex (500 µg + 50 µg) na rynku …
|
Polish | 1.2 KB | ||
| 2019-10-14 15:19 |
Wybór dwóch projektów Spółki do dofinansowania przez NCBiR - Content (PL)
|
Polish | 2.6 KB | ||
| 2019-09-27 17:12 |
Informacja dodatkowa
|
Polish | 1.3 MB | ||
| 2019-09-27 17:12 |
Sprawozdanie z działalności Zarządu
|
Polish | 1.0 MB | ||
| 2019-09-27 17:12 |
Oświadczenie Zarządu
|
Polish | 23.8 KB | ||
| 2019-09-27 17:12 |
Celon HY 2019 Raport
|
Polish | 195.2 KB | ||
| 2019-09-23 16:26 |
Uzyskanie patentu w zakresie Inhibitorów FGFR na terenie Japonii - Content (PL)
|
Polish | 900 bytes | ||
| 2019-08-29 15:42 |
Notyfikacja Glatton Sp. z o.o.
|
Polish | 29.5 KB |
Automate Your Workflow. Get a real-time feed of all Celon Pharma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Celon Pharma S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Celon Pharma S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
